Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InnovAge Holding Corp INNV

Healthcare Drug Manufacturers - Major
InnovAge Holding Corp. is a healthcare delivery platform. The Company is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly... see more

Recent & Breaking News (NDAQ:INNV)

Innovus Pharmaceuticals Reports Record Annual Revenue for Fiscal 2017 of $8.8 Million, Preliminary Q1 2018 Revenue of $4.3 Million to $4.4 Million and Expects to Exit 2018 Profitable

Business Wire April 2, 2018

Innovus Pharmaceuticals to Release Annual 2017 Financial Results, Preliminary First Quarter 2018 Revenues and Provide Corporate Update on Monday, April 2, 2018

Business Wire March 16, 2018

Innovus Pharma to Present at the Sachs BioCapital USA Forum at the New York Academy of Sciences

Business Wire March 9, 2018

Innovus Pharma’s AllerVarx™ Receives Commercial Approval by Health Canada for the Reduction in Symptoms of Seasonal Allergic Rhinitis

Business Wire February 28, 2018

Innovus Pharma Launches its New Brand, Logo and its Latest E-Commerce-Enhanced Content Website

Business Wire February 27, 2018

Innovus Pharma Announces the Complete Repayment in Cash of its Financial Obligations from its Acquisition of its Beyond Human® Assets

Business Wire February 22, 2018

Innovus Pharma Announces the Publication of a Successful Clinical Trial in Overactive Bladder and Urine Incontinence Patients for its UriVarx® Product

Business Wire February 7, 2018

Innovus Pharma Expands Its Sales Channels Through an Alliance with Wellmed, LP to Access Their Extensive Direct Mailing Network of 500,000 Current Customers

Business Wire February 2, 2018

Innovus Pharma’s Apeaz™ Drug for Arthritis Pain Relief Approved for Commercialization in Canada as a Natural Health Product

Business Wire January 30, 2018

Innovus Pharmaceuticals, Inc. Issues Statement Regarding Recent Market Activity Concerning Its Common Stock

Business Wire January 26, 2018

Innovus Pharma Signs Exclusive License and Distribution Agreement with Lavasta Pharma for ProstaGorx® in Certain Middle Eastern and North African Countries

Business Wire January 23, 2018

Innovus Pharma Announces Official Launch of its Amazon®, Walmart®, eBay® and Wish® On-Line Stores with a Combined 116 Product SKUs

Business Wire January 18, 2018

Innovus Pharma Hemorrhoid Drug Xyralid™ Receives Approval in Canada

Business Wire January 16, 2018

Innovus Pharma Announces U.S. Food and Drug Administration Clearance of Its UriVarx® Urinary Tract Infection Test Strips

Business Wire January 11, 2018

Innovus Pharma Enters Into License and Distribution Agreement with Acerus Pharmaceuticals for the Commercialization of UriVarx® in Canada

Business Wire January 8, 2018

Two Innovus Pharma Products Officially Listed in OTC Section of the RED BOOK™

Business Wire December 14, 2017

Innovus Pharma Files Application for the Commercialization of ProstaGorx® for Benign Prostatic Hyperplasia (“BPH”) as a Natural Health Product in Canada

Business Wire December 4, 2017

Innovus Pharma Expands International Distribution by Signing an Exclusive Agreement in Peru with Pharma Solutions for Zestra®, Zestra Glide®, EjectDelay® and Sensum+®

Business Wire December 1, 2017

Innovus Pharma’s Partner Bio Task Receives Approval for Zestra® as a Cosmetic from the National Pharmaceutical Regulatory Agency, Ministry of Health, Malaysia for Arousal and Desire

Business Wire November 29, 2017

Innovus Pharmaceuticals Sponsors 10th Annual LD Micro Investor Conference to be Held on December 5, 2017

Business Wire November 20, 2017